phosphoramidon






507 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
451 18645412 In vivo cerebrovascular effects of cocaine- and amphetamine-regulated transcript (CART) peptide. J Cardiovasc Pharmacol 2008 Jul 1
452 18758506 Effect of the putative novel selective ETA-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature delivery. Can J Physiol Pharmacol 2008 Aug 1
453 18772340 The endothelin-converting enzyme-1/endothelin-1 pathway plays a critical role in inflammation-associated premature delivery in a mouse model. Am J Pathol 2008 Oct 1
454 18804491 Role of the rat gastrointestinal mucosa in catabolism of endothelin peptides. Regul Pept 2008 Nov 29 1
455 18992253 Structure of human endothelin-converting enzyme I complexed with phosphoramidon. J Mol Biol 2009 Jan 9 1
456 19151386 Functional and molecular characterization of the endothelin system in retinal arterioles. Invest Ophthalmol Vis Sci 2009 Jul 3
457 19520130 Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments. Peptides 2009 Sep 1
458 19780404 Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 2009 Sep 1
459 19962413 Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction. Peptides 2010 Feb 1
460 20088804 NEP-like endopeptidases and Alzheimer's disease [corrected]. Curr Alzheimer Res 2010 May 3
461 20504728 Phosphoramidon potentiates the endothelin-1-induced bronchopulmonary response in guinea-pigs. Neurochem Int 1991 5
462 20522806 Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries. Circ Res 2010 Jul 23 1
463 20796280 Autocrine regulation of human sperm motility by tachykinins. Reprod Biol Endocrinol 2010 Aug 26 3
464 20941644 Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice. J Mol Neurosci 2011 Mar 13
465 21174590 Endothelin-1 expression by vascular endothelial growth factor in human umbilical vein endothelial cells and aortic smooth muscle cells. Hypertens Pregnancy 2011 3
466 21224067 Neprilysin-2 is an important β-amyloid degrading enzyme. Am J Pathol 2011 Jan 10
467 21459096 Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation. J Mol Cell Cardiol 2011 Jul 3
468 21651905 Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway. Eur J Pharmacol 2011 Sep 30 2
469 21937235 Structure-based design of dipeptide derivatives for the human neutral endopeptidase. Bioorg Med Chem 2011 Oct 15 2
470 22387410 Context-dependent toxicity of amyloid-β peptides on mouse cerebellar cells. J Alzheimers Dis 2012 1
471 22554773 Neurogenic airway microvascular leakage induced by toluene inhalation in rats. Eur J Pharmacol 2012 Jun 15 1
472 22642296 A smallest 6 kda metalloprotease, mini-matrilysin, in living world: a revolutionary conserved zinc-dependent proteolytic domain- helix-loop-helix catalytic zinc binding domain (ZBD). J Biomed Sci 2012 May 29 1
473 23113990 Dynamic changes in the secondary structure of ECE-1 and XCE account for their different substrate specificities. BMC Bioinformatics 2012 Nov 1 2
474 23528219 Inhibition of neuropeptide degradation suppresses sweating but increases the area of the axon reflex flare. Exp Dermatol 2013 Apr 4
475 23868737 Increase in antinociceptive effect of [leu5]enkephalin after intrathecal administration of mixture of three peptidase inhibitors. Tokai J Exp Clin Med 2013 Jul 20 1
476 23911580 Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568. Pharmacol Res 2013 Oct 2
477 23963369 Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-β peptide(1-40) in mouse brain. J Cereb Blood Flow Metab 2013 Nov 2
478 24000822 Exploring mode of phosphoramidon and Aβ peptide binding to hECE-1 by molecular dynamics and docking studies. Protein Pept Lett 2014 3
479 24069438 Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavage. PLoS One 2013 3
480 24287321 "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting. J Nucl Med 2014 Jan 2
481 25165447 Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance. Front Aging Neurosci 2014 4
482 25286347 In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice. Cancer Biother Radiopharm 2014 Nov 5
483 25457559 γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease. Neurobiol Aging 2015 Feb 2
484 25488751 In vivo radioimaging of bradykinin receptor b1, a widely overexpressed molecule in human cancer. Cancer Res 2015 Jan 15 1
485 25836673 A chicken model of pharmacologically-induced Hirschsprung disease reveals an unexpected role of glucocorticoids in enteric aganglionosis. Biol Open 2015 Apr 2 1
486 26158215 Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting. Q J Nucl Med Mol Imaging 2015 Sep 5
487 26300210 In vivo inhibition of neutral endopeptidase enhances the diagnostic potential of truncated gastrin (111)In-radioligands. Nucl Med Biol 2015 Nov 1
488 26722377 In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies. Theranostics 2016 5
489 26844849 Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon. Cancer Biother Radiopharm 2016 Feb 2
490 26881775 CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis. PLoS One 2016 3
491 26882895 Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation. EJNMMI Res 2016 Dec 4
492 26996808 New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes. Transfusion 2016 May 1
493 27062279 Immature endothelial cells initiate endothelin-mediated constriction of newborn arteries. J Physiol 2016 Sep 1 1
494 27840228 Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry. Peptides 2017 Jan 2
495 28636973 Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. Nucl Med Biol 2017 Sep 4
496 29556947 In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer. Mol Imaging Biol 2018 Dec 5
497 29664606 Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin. Bioconjug Chem 2018 May 16 2
498 30002107 Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog <sup>177</sup>Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution? J Nucl Med 2019 Mar 1
499 30082509 Phosphoramidon inhibits the integral membrane protein zinc metalloprotease ZMPSTE24. Acta Crystallogr D Struct Biol 2018 Aug 1 4
500 30537985 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease. Acta Neuropathol Commun 2018 Dec 11 1